Skip to content

Select Medical Holdings SEM Long-Term Debt - Fair Value

Long-Term Debt - Fair Value at other companies

Celcuity logo
CelcuityCELC
$167.8M
Sylvamo logo
SylvamoSLVM
$842M+5.8%
Tyson Foods logo
Tyson FoodsTSN
$7.82B-11.3%
PPG Industries logo
PPG IndustriesPPG
$7.22B+28.1%
SBA Communications logo
SBA CommunicationsSBAC
$12.53B+6.7%
Southern Company logo
Southern CompanySO
$66.5B

Other financials

Income statement

See full
Revenue$1.4B+5.0%
Gross profit$175.5M-2.8%
Operating income$98.4M-12.7%
Net income$44.0M-22.4%
EPS (diluted)$0.35-20.5%

Balance sheet

See full
Cash & equivalents$25.7M-51.7%
Total debt$3.0B+7.5%
Total equity$1.8B+2.1%
Total assets$6.0B+6.1%

Cash flow

See full
Operating cash flow$37.9M+1,195%
CapEx$58.9M+12.5%
Free cash flow-$21.0M+62.3%

Valuation

See full
Market cap$2.05B-6.2%

Profitability

See full
Gross margin11.3%-0.5pp
Operating margin5.8%+0.8pp
Net margin2.4%-0.9pp
FCF margin2.8%-4.1pp

Returns & leverage

See full
Return on equity7.7%-3.6pp
Debt / equity1.7×+0.1×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Select Medical Holdings in its filing.

Tagged under the XBRL concept us-gaap:DebtInstrumentFairValue.

The official record: Select Medical Holdings’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Select Medical Holdings's long-term debt - fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Select Medical Holdings's long-term debt - fair value?
Select Medical Holdings (SEM) reported long-term debt - fair value of $1.84B in Q1 2026.
How has Select Medical Holdings's long-term debt - fair value changed year-over-year?
Select Medical Holdings's long-term debt - fair value increased by 2.5% year-over-year, from $1.79B to $1.84B.
What is the long-term trend for Select Medical Holdings's long-term debt - fair value?
Over 5 years (2020 to 2025), Select Medical Holdings's long-term debt - fair value has grown at a -12.1% compound annual growth rate (CAGR), from $3.47B to $1.83B.